Zentalis Pharmaceuticals (ZNTL) Receivables - Net (2019 - 2024)

Zentalis Pharmaceuticals' Receivables - Net history runs 4 years deep, the most recent figure standing at $5.0 million for Q4 2024.

• In Q4 2024, Receivables - Net changed N/A year-over-year to $5.0 million; the TTM figure through Dec 2024 stood at $5.0 million (changed N/A YoY), while the FY2024 annual figure was $5.0 million, changed N/A from the prior year.
• Receivables - Net for Q4 2024 stood at $5.0 million, up from $4000.0 in the prior quarter.
• The five-year high for Receivables - Net was $5.0 million in Q4 2024, with the low at $4000.0 in Q4 2021.
• The 3-year median for Receivables - Net is $122000.0 (2020), against an average of $679555.6.
• The sharpest annual moves came in 2020 and 2021: Receivables - Net soared 197.86% in 2020, then plunged 99.04% in 2021.
• Zentalis Pharmaceuticals' Receivables - Net stood at $417000.0 in 2020, then slumped by 99.04% to $4000.0 in 2021, then surged by 124900.0% to $5.0 million in 2024.
• Business Quant data shows ZNTL's Receivables - Net at $5.0 million in Q4 2024, $4000.0 in Q4 2021, and $108000.0 in Q3 2021.